$143.31
-0.40[-0.28%]
At close: Apr 26
$143.31
0[0.00%]
After Hours: 4:20PM EDT
Alnylam Pharmaceuticals: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Mar 01, 2024 | Phillip A Sharp | DIRECTOR | 0 | $105.29 | -$2.76M | SELL-OPTIONS | 0.00% | 266.899K | Feb 29 | View |
Feb 29, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 1.166K | $155.30 | -$77.81K | SELL-OPTIONS | 28.65% | 5.236K | Feb 27 - Feb 28 | View |
Feb 29, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 1.334K | $155.30 | -$89.14K | SELL-OPTIONS | 7.33% | 19.535K | Feb 27 - Feb 28 | View |
Feb 29, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 2.989K | $155.31 | -$455.36K | SELL-OPTIONS | 6.56% | 48.535K | Feb 27 - Feb 28 | View |
Feb 29, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 1.334K | $155.30 | -$89.14K | SELL-OPTIONS | 17.59% | 8.916K | Feb 27 - Feb 28 | View |
Feb 29, 2024 | Indrani Franchini | EVP, CLO & SECRETARY | 549 | $155.30 | -$51.09K | SELL-OPTIONS | 15.32% | 4.133K | Feb 27 - Feb 28 | View |
Feb 20, 2024 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 2.987K | $148.06 | -$193.67K | GRANT | 65.01% | 7.582K | Feb 15 - Feb 16 | View |
Feb 20, 2024 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 2.271K | $148.06 | -$149.10K | GRANT | 14.26% | 18.201K | Feb 15 - Feb 16 | View |
Feb 20, 2024 | Tolga Tanguler | EVP, CHIEF COMMERCIAL OFFICER | 2.269K | $148.06 | -$149.40K | GRANT | 125.99% | 4.07K | Feb 15 - Feb 16 | View |
Feb 20, 2024 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 9.923K | $148.06 | -$1.04M | GRANT | 27.86% | 45.546K | Feb 15 - Feb 16 | View |
Feb 05, 2024 | Indrani Franchini | EVP, CLO & SECRETARY | 3.584K | $170.99 | -$272.05K | SELL-OPTIONS | ∞ | 3.584K | Feb 01 - Feb 02 | View |
Dec 29, 2023 | Michael W Bonney | DIRECTOR | 0 | $145.72 | -$2.96M | SELL-OPTIONS | 0.00% | 20.029K | Dec 27 | View |
Aug 07, 2023 | Pushkal Garg | CMO & EVP DEV & MED AFFAIRS | 0 | $184.78 | -$1.41M | GRANT | 0.00% | 4.595K | Aug 03 - Aug 07 | View |
Aug 07, 2023 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 4.167K | $185.85 | -$643.04K | GRANT | 35.42% | 15.93K | Aug 03 - Aug 04 | View |
Aug 07, 2023 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 4.884K | $185.85 | -$753.99K | GRANT | 15.89% | 35.623K | Aug 03 - Aug 04 | View |
Aug 07, 2023 | Akshay Vaishnaw | PRESIDENT | 4.884K | $185.85 | -$753.99K | GRANT | 26.54% | 23.289K | Aug 03 - Aug 04 | View |
Aug 04, 2023 | Michael W Bonney | DIRECTOR | 16.029K | $185.38 | -$1.20M | SELL-OPTIONS | 400.73% | 20.029K | Aug 02 - Aug 03 | View |
Apr 28, 2023 | Yvonne Greenstreet | CHIEF EXECUTIVE OFFICER | 9.337K | $194.59 | -$1.48M | GRANT | 43.63% | 30.739K | Apr 26 - Apr 27 | View |
Apr 28, 2023 | Jeffrey V Poulton | EVP, CHIEF FINANCIAL OFFICER | 2.3K | $194.59 | -$190.11K | GRANT | 24.31% | 11.763K | Apr 26 - Apr 27 | View |
Browse insider trades on all stocks.